Trial intelligence / Profile preview

Intermittent vs Continuous Surface Oxygenation in Kidney HMP

NCT05430620Phase 3Recruiting

Start
Mar 2022
Primary completion
Jan 2025
Modality
Inhalation Devices
Countries
1
01

Overview

A Phase 3 trial of oxygen in delayed graft function (DGF), ischemia-reperfusion injury (IRI). Started Mar 2022; status: recruiting.

02

Drugs

oxygen
03

Conditions

delayed graft function (DGF)ischemia-reperfusion injury (IRI)

Beyond the preview

Go deeper on NCT05430620.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05430620.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call